Researcher
Geoffrey Férir
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From5 Jul 2004 → 31 Dec 2014
Projects
1 - 1 of 1
- Anti-HIV activity and mode of action of naturally occurring peptides interfering with the viral entry processFrom1 Oct 2009 → 3 Jun 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 14
- The low-cost compound lignosulfonic acid (LA) exhibits broad-spectrum anti-HIV and anti-HSV activity and has potential for microbicidal applications(2015)
Authors: Stephanie Gordts, Geoffrey Férir, Thomas D'huys, Mariya Petrova, Sarah Lebeer, Robert Snoeck, Graciela Andrei, Dominique Schols
- HIV-1 and its resistance to peptidic carbohydrate-binding agents (CBAs): An overview(2014)
Authors: Geoffrey Férir, Stephanie Gordts, Dominique Schols
Pages: 21085 - 21112 - Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin famil(2014)
Authors: Geoffrey Férir, Dana Huskens, Sam Noppen, Dominique Schols
Pages: 2746 - 2758 - Anti-HIV activity and mode of action of naturally occurring peptides interfering with the viral entry process(2013)
Authors: Geoffrey Férir, Dominique Schols, Paul Proost
- The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with Potential for Microbicidal Applications(2013)
Authors: Geoffrey Férir, Mariya Petrova, Graciela Andrei, Robert Snoeck, Jos Vanderleyden, Jan Balzarini, Dominique Schols
- Griffithsin, alone and combined with all classes of antiretroviral drugs, potently inhibits HIV cell-cell transmission and destruction of CD4+ T cells(2012)
Authors: Geoffrey Férir, Dominique Schols
Pages: 103 - 112 - Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120(2012)
Authors: Geoffrey Férir, Bart Hoorelbeke, Dana Huskens, Dominique Schols
Pages: 308 - 319 - Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV type 1, HIV type 2, and selected carbohydrate-binding agent-resistant HIV type 1 strains(2012)
Authors: Geoffrey Férir, Dana Huskens, Jan Balzarini, Dominique Schols
Pages: 1513 - 1523 - Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C(2011)
Authors: Geoffrey Férir, Dominique Schols
Pages: 253 - 258 - Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs)(2011)
Authors: Geoffrey Férir, Kurt Vermeire, Dana Huskens, Jan Balzarini, Dominique Schols
Pages: 200 - 204